Kenya has abruptly suspended construction of a US-funded Ebola treatment facility near the Somali border, with UK health officials tabling an alternative proposal that could reshape regional pandemic preparedness. The decision, announced late Tuesday by Kenya’s health ministry, follows months of diplomatic tension over the centre’s location and operational protocols.
The halted facility, a $15 million project backed by the US Centers for Disease Control and Prevention (CDC), was intended to serve as a regional hub for containing viral haemorrhagic fevers. However, local officials and community leaders raised concerns about the centre’s proximity to densely populated refugee camps, fearing potential stigma and accidental pathogen release. The US embassy in Nairobi expressed disappointment, stating the centre would have employed advanced biocontainment technology, including negative-pressure isolation units and real-time genomic sequencing capabilities.
Stepping into the void, the UK’s Foreign, Commonwealth & Development Office (FCDO) has proposed a decentralised network of mobile diagnostic labs paired with AI-driven predictive surveillance. This model, already trialled in Sierra Leone, uses machine learning to analyse sewage, travel patterns, and livestock mortality for early outbreak signals. The UK’s plan also includes a digital health pass system using blockchain for secure vaccination records, a move that aligns with Kenya’s recent push for digital sovereignty in health data.
‘The US approach was a Cold War-era solution: a fortress lab. We need elastic resilience, not concrete,’ said Dr. Amina Yusuf, a UK health advisor familiar with the proposal. ‘Kenya’s mobile penetration is over 100% – why not leverage that for real-time community reporting instead of relying on a single facility that could become a target?’
The suspension underscores a broader shift in global health governance, as LMICs resist top-down infrastructure projects. Kenya’s health cabinet secretary, Mutahi Kagwe, emphasised the need for ‘culturally sensitive and digitally autonomous’ systems, echoing a sentiment gaining traction across Africa. The controversy also exposes the ethical tightrope of biodefence: the US facility was partly funded under the Global Health Security Agenda, a programme critics label a soft-power tool for monitoring emerging pathogens.
Meanwhile, the UK’s intervention is not without its own complications. The proposed digital health pass could exacerbate inequalities, as 35% of Kenyans lack access to smartphones. ‘An app-based system risks creating a two-tier surveillance framework where the wealthy are monitored in real-time while the poor disappear from the data grid,’ warned Keziah Mbogho, a digital rights activist in Nairobi.
As negotiations continue, the WHO has expressed cautious support for the UK’s modular approach, while urging transparency. The US, for its part, has indicated it will redirect funds to bolster community health workers in the region. But the core question remains: can pandemic preparedness be both technologically advanced and ethically sound? Kenya’s decision suggests the answer lies not in choosing between labs and phones, but in designing systems that earn trust through equity and agency.
For now, the skeletal framework of the cancelled US facility stands silent on the dusty plains of Garissa County, a monument to the tensions between global health security and local autonomy. The UK’s alternative plan may yet rise from that dust, but only if it can prove that Silicon Valley-style disruption works as well in the bush as it does in boardrooms.
